sandro_pasquali Profile Banner
Sandro Pasquali Profile
Sandro Pasquali

@sandro_pasquali

Followers
675
Following
256
Statuses
3K

Clinician scientist at Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.

Joined March 2013
Don't wanna be here? Send us removal request.
@sandro_pasquali
Sandro Pasquali
2 months
RT @ESSOnews: 🎥 Dr. Marco Fiore @FioreDoc, Director of the European School of Soft Tissue Sarcoma Surgery (ESSTSS), invites you to join thi…
0
4
0
@sandro_pasquali
Sandro Pasquali
3 months
RT @IstTumori: 🎉 Siamo orgogliosi di annunciare che la Dr.ssa Silvia Stacchiotti ha ricevuto un prestigioso riconoscimento agli Italian Kno…
0
13
0
@sandro_pasquali
Sandro Pasquali
3 months
RT @IstTumori: La vita di 25 giovani pazienti oncologici in una sitcom:quando e dove vederla. Realizzata in collaborazione con Mediafriends…
0
6
0
@sandro_pasquali
Sandro Pasquali
3 months
RT @RLRandallMD: Kudos to Robert Maki,MD,past President of @ctos, an extraordinary person & med onc for giving the annual Nina Axelrad Lect…
0
11
0
@sandro_pasquali
Sandro Pasquali
3 months
RT @alegronchi: Prof. Bruno Vincenzi at @ctosociety annual meeting presents a post-hoc analysis on high risk progressing desmoid tumor with…
0
2
0
@sandro_pasquali
Sandro Pasquali
3 months
RT @alegronchi: @Dan_Salvatore presenting at the @ctosociety annual meeting in San Diego the #RESAR platform and framework agreement, which…
0
7
0
@sandro_pasquali
Sandro Pasquali
3 months
RT @CureSarcoma: We're at #CTOS2024 sharing our poster on the patient experience with liposarcoma! Our poster "Patient Perspective on Lip…
0
1
0
@sandro_pasquali
Sandro Pasquali
3 months
RT @andrea_franza: Postcards from #CTOS2024 day2: opening ceremony, a great presentation by @radaste for SACRO study and some good talks at…
0
2
0
@sandro_pasquali
Sandro Pasquali
3 months
RT @CareSarcoma: Don't miss our poster No 188 @ctosociety #CTOS2024 elaborating the Burdens of Caregivers to Sarcoma Patients and how to re…
0
4
0
@sandro_pasquali
Sandro Pasquali
3 months
RT @TGCTSupportorg: @WTapMD shows that Pexidartinib tumor response is unaffected by prior surgeries but Pexidartinib may have higher benefi…
0
1
0
@sandro_pasquali
Sandro Pasquali
3 months
RT @andrea_franza: Wrapping up last day of #CTOS2024! Again, so many interesting presentations, a fantastic crew of colleagues/friends and…
0
1
0
@sandro_pasquali
Sandro Pasquali
3 months
Tweet media one
0
12
0
@sandro_pasquali
Sandro Pasquali
3 months
RT @RyanDenu: Great talk at @ctosociety by @APConley77 describing impressive results of an oncolytic virus with TGF beta trap for sarcoma.…
0
7
0
@sandro_pasquali
Sandro Pasquali
3 months
RT @wagsmd: Doxorubicin +/- pembro trial open now! Saw some impressive activity in the initial phase2, hopefully will be confirmed! ⁦@immun
0
10
0
@sandro_pasquali
Sandro Pasquali
3 months
RT @alegronchi: 2/4 the implication of histologic organ infiltration for surgical strategy and risk of recurrence, the natural history of P…
0
7
0
@sandro_pasquali
Sandro Pasquali
3 months
RT @alegronchi: 4/4 And the next level of collaboration is now under construction... @ctosociety @IstTumori @SocSurgOnc @ESSOnews @myESMO @…
0
7
0
@sandro_pasquali
Sandro Pasquali
3 months
RT @alegronchi: ¼ Great #retroperitoneal #sarcoma session at @ctosociety today. Lots of data coming from international collaboration to und…
0
10
0
@sandro_pasquali
Sandro Pasquali
3 months
RT @pawel_sobczuk: Very interesting data from @TARPSWG about concordance of histology and grade accuracy between biopsy and surgical materi…
0
10
0
@sandro_pasquali
Sandro Pasquali
3 months
RT @seppobauer: We must not give up on MDM2 inhibitors in LPS. Despite a negative trial. The signal of targeting a tumor suppressor in Bri…
0
10
0
@sandro_pasquali
Sandro Pasquali
3 months
RT @DAmbrosio_MD: Great #CTOS 2024 Annual Meeting in San Diego! Always a unique time for ideas exchange and meeting new and old friends fro…
0
8
0